BHC - Bausch Health Corp Sales Growth YoY (Last Twelve Months)

Graphic logo of Bausch Health Corp (BHC)

Bausch Health Companies (BHC) relies on inelastic demand in gastroenterology and ophthalmology, maintaining moderate pricing power due to its debt load. This rolling year-over-year revenue growth chart confirms this trend, where the 10.80 level indicates the parameter's status. The sale of lenses and prescription drugs to clinics serves as a cash generator. The industry's humanitarian status and diversified supply chains guarantee stability.

BHC Bausch Health: Revenue Growth YoY (Last 12 Months) in the range 02/11/2024 - 11/18/2026

Bausch Health Companies Inc. (BHC) - metric breakdowns and financial figures

Summary company analytics:Bausch Health Companies
Signature product of Bausch Health

For Bausch Health Companies (BHC), which relies on trust in the Bausch + Lomb brands and dermatology drugs, this indicator serves as a measure of market expansion. The metric calculates the percentage change in revenue over the last twelve months, excluding quarterly distortions. By analyzing the annual revenue growth from sales over a rolling period, an investor can see the real demand dynamics. Sharp deviations on the chart signal business overheating or stagnation.